Companion Animal Genetics Market Poised for Robust Growth, Projected to Reach USD 1.93 Billion by 2035

The global companion animal genetics market, valued at USD 865.1 million in 2025, is projected to expand significantly, reaching USD 1,932.7 million by 2035, reflecting a robust compound annual growth rate (CAGR) of 8.4% over the next decade. This growth is driven by an increasing demand for genetic testing, breeding solutions, and disease risk assessments for dogs, cats, and other companion animals. A notable surge in DNA-based diagnostics, precision breeding tools, and genetic health screening services is reshaping the veterinary care landscape, establishing genetic testing as an essential part of modern pet healthcare.

Unlock detailed analytics - Request your personalized report now! https://www.futuremarketinsights.com/reports/sample/rep-gb-26312

Key Market Drivers

Several factors are fueling this market expansion. Pet ownership, particularly in North America, Europe, and Asia Pacific, continues to rise, with pet owners increasingly prioritizing the health and well-being of their companion animals. The market is also being bolstered by the growing trend of "pet humanization," where pets are treated as family members, leading to higher spending on advanced veterinary services, including genetic testing. The demand for genetic testing is further stimulated by its ability to offer preventive care solutions, such as identifying hereditary conditions and optimizing breeding decisions, ensuring healthier animals and reducing the prevalence of genetic disorders.

Technological advancements are another critical growth driver. AI-powered genetic analysis tools are revolutionizing the field, enhancing diagnostic accuracy and increasing the accessibility of genetic testing. Moreover, the availability of online platforms and tele-veterinary services is improving convenience for pet owners, especially in emerging markets such as India and China, where the pet industry is experiencing rapid growth.

Competitive Landscape

The competitive landscape of the companion animal genetics market is evolving, with key players such as Zoetis Services LLC, Neogen Corporation, and Antech Diagnostics Inc. maintaining strong positions. Zoetis, a leader in veterinary diagnostics, provides comprehensive genetic testing services for a range of companion animals, focusing on disease risk assessment and breed verification. Neogen Corporation, with its extensive portfolio of breeding-specific genetic tests, caters primarily to breeders and pet owners seeking to make informed decisions regarding the health and traits of their animals.

Embark Veterinary Inc., Basepaws, and Orivet Genetic Pet Care are making significant strides by offering direct-to-consumer (DTC) genetic testing platforms, which have gained popularity among pet owners. Embark's emphasis on canine genetics, including breed identification and health risk evaluation, and Basepaws' feline genomics solutions are catering to the growing demand for personalized pet care. Meanwhile, UC Davis Veterinary Genetics Laboratory (VGL) and ZOOGEN continue to support both clinical applications and research initiatives, enhancing the overall credibility and innovation in the market.

Additionally, Generatio GmbH and Animal Genetics Inc. are offering tailored testing for specific breeds and rare genetic disorders, contributing to the niche segment of the market. These companies, alongside emerging players, are expected to intensify competition, leading to further innovation in genetic testing services and expanded market reach.

Regional Market Analysis

North America remains the largest market, with the U.S. contributing to a significant portion of the market share. The strong veterinary infrastructure, coupled with high pet ownership rates and a willingness to spend on advanced pet care, continues to drive the demand for genetic testing services. The region is home to a variety of companies offering comprehensive solutions, from disease risk assessments to breeding optimization tools.

Asia Pacific, especially China and India, are emerging as key growth regions. China's CAGR is projected at 11.3%, fueled by increasing pet ownership and growing awareness of the benefits of genetic testing. Similarly, India's CAGR of 10.5% is supported by expanding veterinary infrastructure and rising demand for personalized veterinary care. The increased adoption of tele-veterinary services and online genetic testing kits in these regions is further enhancing market accessibility.

In Europe, countries like Germany and the United Kingdom are leading the way, with a growing focus on precision veterinary care. The demand for genetic testing solutions in these countries is driven by a combination of high pet ownership and sophisticated veterinary practices that emphasize preventive care and responsible breeding practices.

Segmental Breakdown

By Animal Type, dogs dominate the companion animal genetics market, accounting for 49% of the market share in 2025. Pet owners are increasingly seeking genetic tests for dogs due to the broad range of breeds, each with its unique set of genetic health risks and traits. The genetic disease testing segment is expected to hold the largest market share at 57%, as pet owners and veterinarians prioritize the early detection of hereditary conditions to guide breeding decisions and preventive care.

By Distribution Channel, the private sector is expected to lead with a 76% share, as pet owners continue to rely on private veterinary practices and direct-to-consumer platforms for genetic testing services. This preference is largely driven by convenience and personalized care options offered by private sector providers.

Conclusion

The companion animal genetics market is experiencing a period of rapid growth, driven by technological advancements, rising pet ownership, and increasing consumer demand for personalized, preventive veterinary care. As the market evolves, competition will intensify, with both established players and emerging direct-to-consumer platforms vying for a share of this lucrative market. With a projected CAGR of 8.4% from 2025 to 2035, the companion animal genetics market presents significant opportunities for companies, investors, and pet owners alike.

Get Full Access of this Report:
https://www.futuremarketinsights.com/reports/companion-animal-genetics-market

Explore Related Research Reports on Healthcare Domain

Nucleic Acid Test Kits for Pets Market:
https://www.futuremarketinsights.com/reports/nucleic-acid-test-kits-for-pets-market

Veterinary Pain Management Drugs Market:
https://www.futuremarketinsights.com/reports/veterinary-pain-management-drugs-market

Avian Flu Treatment Market:
https://www.futuremarketinsights.com/reports/avian-flu-treatment-market

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

This release was published on openPR.